Global Neglected Tropical Disease (NTD) Treatment Market, Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2029
“Global Neglected Tropical Disease (NTD) Treatment Market” is the title of an exhaustive market research report offering by MarketResearch.biz. Critical factors are analyzed and studied comprehensively and vital data & information are presented in a well-planned flow and format in this report. In addition to the revenue shares of each segment, region, and country, revenue growth driving factors, restraints, as well as the opportunities in untapped economies are included. The company profiles of key players comprise detailed information, recent developments, strategies, and acquisitions & mergers, etc. The global neglected tropical disease (NTD) treatment market is segmented by diseases, product types, and regions & countries.
Global Neglected Tropical Disease (NTD) Treatment Market: Overview
Neglected tropical diseases (NTDs) are a group of tropical infections that are highly prevalent in low-income regions in Africa, Asia, and the Americas. They are caused by a variety of pathogens such as viruses and bacteria, and other pathogens such as protozoa and helminths. The big-three diseases like HIV/AIDS, tuberculosis and malaria do not fall under the category of NTD. However, NTDs aggravate the condition of patients suffering from HIV/AIDS and tuberculosis.
Relevant issues like sanitation, neatness, and cleanliness are some of the major factors that are essential with regard to NTD treatment. NTDs are the outcome of failure in maintaining one’s hygiene. World Health Organization states that NTDs influence close to 1 billion individuals across the globe.
Global Neglected Tropical Disease (NTD) Treatment Market: Dynamics
Drivers: Growing awareness and improvements in the healthcare industry in terms of treatment facilities for patients are among major factors that are expected to be driving the growth of the global Neglected Tropical Disease Treatment Market.
An increasing number of initiatives are being undertaken by the government in addressing the issue of NTDs. This is expected to drive the growth of the Neglected Tropical Disease Treatment Market exponentially. The inclusion of NTDs in the Sustainable Development Goals (SDG) (a United Nations Development Programme) will act as a driving catalyst in fuelling the growth of the global neglected tropical disease treatment market.
Restraints: The high cost of treatment and medication are expected to restrain market growth due to the inability of individuals who belong to low-income regions to afford them.
Global Neglected Tropical Disease (NTD) Market: Segmentation analysis
By Product Type: Among the disease segments, Dengue is expected to account for the largest revenue share due to its increasing prevalence.
By Application: Among the product segments, due to the increasing number of pipeline products, the vaccines segment is projected to index the fastest growth over the 10-year forecast period.
Global Neglected Tropical Disease (NTD) Market: Regional Analysis
The Asia Pacific market is expected to dominate the global market for neglected tropical disease treatment over the 10-year forecast period. This can be attributed to factors such as the high prevalence of neglected tropical diseases, rising disposable income, and an ever-increasing population in the region.
Latin America market is projected to continue to register a high Compounded Annual Growth Rate (CAGR). Rising awareness regarding treatment for NTDs among of patients suffering from the disease in Latin America with respect to the methods of tackling neglected tropical diseases are factors expected to propel growth of the Latin America market.
The markets of the Middle East and Africa (MEA) are expected to account for the second-highest revenue share in the forecast period owing to the escalating recurrence of NTDs in the MEA market. In 2017 for instance, as per published report by the Uniting to Combat NTDs, the statistics stated that over 600 million individuals got affected by NTDs in the Africa region.
Global Neglected Tropical Disease (NTD) Market Segmentation:
- Buruli Ulcer
- Chagas Disease
- Human African Trypanosomiasis (Sleeping Sickness)
- Soil-Transmitted Helminthiases
By Product Type:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2019 Estimated Year 2020 Forecast Period 2020–2029 Revenue in US$
- Hoffmann-La Roche Ltd
- Bayer AG
- GlaxoSmithKline plc
- Novartis AG
- Pfizer Inc.
- Eisai Co. Ltd.
- Astellas Pharma
- Takeda Pharmaceutical Company Limited and Gilead Sciences
- Ford GoBike
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!